Search

Your search keyword '"Lahner H"' showing total 7 results
Start Over Author "Lahner H" Publication Type Electronic Resources
7 results on '"Lahner H"'

1. [Somatostatin receptor PET/CT (SSTR-PET/CT)]

Author

Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P., Buchmann, I., Ezziddin, S., Fuhrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H.R., Nagarajah, J., Rosch, F., Scheidhauer, K., Schmidt, M., Walter, M.A., Bockisch, A., Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P., Buchmann, I., Ezziddin, S., Fuhrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H.R., Nagarajah, J., Rosch, F., Scheidhauer, K., Schmidt, M., Walter, M.A., and Bockisch, A.

Abstract

Item does not contain fulltext, The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. The document has been developed by a multidisciplinary board of specialists providing consensus of definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands of human SSTR, i. e. 68Ga-DOTATOC and 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication and cooperation of referring and executing medical disciplines, taking into account existing guidelines and recommendations of the European and German medical societies, including the European Association of Nuclear Medicine (EANM), German Society for Endocrinology (DGE), German Society for Nuclear Medicine (DGN) and German Society for Radiology (DRG).

Published
2018

2. Somatostatin receptor PET/CT (SSTR-PET/CT)

Author

Boy, C., Poeppel, T., Kotzerke, J., Krause, B. J., Amthauer, H., Baum, R. P., Buchmann, I., Ezziddin, S., Fuehrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H. R., Nagarajah, J., Roesch, F., Scheidhauer, K., Schmidt, M., Walter, M. A., Bockisch, A., Boy, C., Poeppel, T., Kotzerke, J., Krause, B. J., Amthauer, H., Baum, R. P., Buchmann, I., Ezziddin, S., Fuehrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H. R., Nagarajah, J., Roesch, F., Scheidhauer, K., Schmidt, M., Walter, M. A., and Bockisch, A.

Abstract

The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. The document has been developed by a multidisciplinary board of specialists providing consensus of definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands of human SSTR, i.e. 68Ga-DOTATOC and 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication and cooperation of referring and executing medical disciplines, taking into account existing guidelines and recommendations of the European and German medical societies, including the European Association of Nuclear Medicine (EANM), German Society for Endocrinology (DGE), German Society for Nuclear Medicine (DGN) and German Society for Radiology (DRG).

Published
2018

3. [Somatostatin receptor PET/CT (SSTR-PET/CT)]

Author

Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P., Buchmann, I., Ezziddin, S., Fuhrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H.R., Nagarajah, J., Rosch, F., Scheidhauer, K., Schmidt, M., Walter, M.A., Bockisch, A., Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P., Buchmann, I., Ezziddin, S., Fuhrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H.R., Nagarajah, J., Rosch, F., Scheidhauer, K., Schmidt, M., Walter, M.A., and Bockisch, A.

Abstract

Item does not contain fulltext, The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. The document has been developed by a multidisciplinary board of specialists providing consensus of definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands of human SSTR, i. e. 68Ga-DOTATOC and 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication and cooperation of referring and executing medical disciplines, taking into account existing guidelines and recommendations of the European and German medical societies, including the European Association of Nuclear Medicine (EANM), German Society for Endocrinology (DGE), German Society for Nuclear Medicine (DGN) and German Society for Radiology (DRG).

Published
2018

4. [Somatostatin receptor PET/CT (SSTR-PET/CT)]

Author

Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P., Buchmann, I., Ezziddin, S., Fuhrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H.R., Nagarajah, J., Rosch, F., Scheidhauer, K., Schmidt, M., Walter, M.A., Bockisch, A., Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P., Buchmann, I., Ezziddin, S., Fuhrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H.R., Nagarajah, J., Rosch, F., Scheidhauer, K., Schmidt, M., Walter, M.A., and Bockisch, A.

Abstract

Item does not contain fulltext, The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. The document has been developed by a multidisciplinary board of specialists providing consensus of definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands of human SSTR, i. e. 68Ga-DOTATOC and 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication and cooperation of referring and executing medical disciplines, taking into account existing guidelines and recommendations of the European and German medical societies, including the European Association of Nuclear Medicine (EANM), German Society for Endocrinology (DGE), German Society for Nuclear Medicine (DGN) and German Society for Radiology (DRG).

Published
2018

5. Somatostatin receptor PET/CT (SSTR-PET/CT)

Author

Boy, C., Poeppel, T., Kotzerke, J., Krause, B. J., Amthauer, H., Baum, R. P., Buchmann, I., Ezziddin, S., Fuehrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H. R., Nagarajah, J., Roesch, F., Scheidhauer, K., Schmidt, M., Walter, M. A., Bockisch, A., Boy, C., Poeppel, T., Kotzerke, J., Krause, B. J., Amthauer, H., Baum, R. P., Buchmann, I., Ezziddin, S., Fuehrer, D., Gabriel, M., Kuwert, T., Lahner, H., Lauenstein, T., Maecke, H. R., Nagarajah, J., Roesch, F., Scheidhauer, K., Schmidt, M., Walter, M. A., and Bockisch, A.

Abstract

The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. The document has been developed by a multidisciplinary board of specialists providing consensus of definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands of human SSTR, i.e. 68Ga-DOTATOC and 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication and cooperation of referring and executing medical disciplines, taking into account existing guidelines and recommendations of the European and German medical societies, including the European Association of Nuclear Medicine (EANM), German Society for Endocrinology (DGE), German Society for Nuclear Medicine (DGN) and German Society for Radiology (DRG).

Published
2018

6. Neuroendocrine neoplasms of the distal jejunum and ileum

Author

Anlauf, M., Sipos, B., Boeck, I., Baldus, S. E., Heikaus, S., Krausch, M., Knoefel, W. T., Begum, N., Goretzki, P., Schott, M., Auernhammer, C. J., Cremer, B., Rinke, A., Ezziddin, S., Fottner, C., Poepperl, G., Lahner, H., Hoersch, D., Gabbert, H. E., Komminoth, P., Perren, A., Kloeppel, G., Wiedenmann, B., Pavel, M., Pape, U., Anlauf, M., Sipos, B., Boeck, I., Baldus, S. E., Heikaus, S., Krausch, M., Knoefel, W. T., Begum, N., Goretzki, P., Schott, M., Auernhammer, C. J., Cremer, B., Rinke, A., Ezziddin, S., Fottner, C., Poepperl, G., Lahner, H., Hoersch, D., Gabbert, H. E., Komminoth, P., Perren, A., Kloeppel, G., Wiedenmann, B., Pavel, M., and Pape, U.

Abstract

Neuroendocrine neoplasms (NEN) of the distal jejunum and ileum derive from serotonin-producing enterochromaffin (EC) cells. Due to their low proliferation rate and their infiltrative growth, they are often discovered at an advanced disease stage when metastasis has already occurred. The biology of these tumours is different from other NEN of the digestive tract. In order to standardise and improve diagnosis and therapy, the guidelines for the diagnosis and clinical management of jejuno-ileal NEN as well as for the management of patients with liver and other distant metastases from NEN were revised by the European Neuroendocrine Tumour Society (ENETS) in 2012. This review focuses on aspects relevant for surgical pathology.

Published
2014

7. Neuroendocrine neoplasms of the distal jejunum and ileum

Author

Anlauf, M., Sipos, B., Boeck, I., Baldus, S. E., Heikaus, S., Krausch, M., Knoefel, W. T., Begum, N., Goretzki, P., Schott, M., Auernhammer, C. J., Cremer, B., Rinke, A., Ezziddin, S., Fottner, C., Poepperl, G., Lahner, H., Hoersch, D., Gabbert, H. E., Komminoth, P., Perren, A., Kloeppel, G., Wiedenmann, B., Pavel, M., Pape, U., Anlauf, M., Sipos, B., Boeck, I., Baldus, S. E., Heikaus, S., Krausch, M., Knoefel, W. T., Begum, N., Goretzki, P., Schott, M., Auernhammer, C. J., Cremer, B., Rinke, A., Ezziddin, S., Fottner, C., Poepperl, G., Lahner, H., Hoersch, D., Gabbert, H. E., Komminoth, P., Perren, A., Kloeppel, G., Wiedenmann, B., Pavel, M., and Pape, U.

Abstract

Neuroendocrine neoplasms (NEN) of the distal jejunum and ileum derive from serotonin-producing enterochromaffin (EC) cells. Due to their low proliferation rate and their infiltrative growth, they are often discovered at an advanced disease stage when metastasis has already occurred. The biology of these tumours is different from other NEN of the digestive tract. In order to standardise and improve diagnosis and therapy, the guidelines for the diagnosis and clinical management of jejuno-ileal NEN as well as for the management of patients with liver and other distant metastases from NEN were revised by the European Neuroendocrine Tumour Society (ENETS) in 2012. This review focuses on aspects relevant for surgical pathology.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results